Article Data

  • Views 300
  • Dowloads 47

Original Research

Open Access

Management Issues of Neuropathic Trigeminal Pain from a Medical Perspective

  • C. Peter N. Watson1,*,

1Department of Medicine, University of Toronto, Toronto, Ontario, Canada

DOI: 10.11607/jofph.18366 Vol.18,Issue 4,December 2004 pp.366-373

Published: 30 December 2004

*Corresponding Author(s): C. Peter N. Watson E-mail:

Abstract

The purpose of this article is to review the pharmacological treat-ment of neuropathic trigeminal pain by means of a systematic review. A number of randomized controlled trials and important historical and uncontrolled studies in trigeminal neuralgia and postherpetic neuralgia were identified. Trigeminal neuralgia is a unique neuropathic pain disorder with a specific therapy. It does not respond to the usual drugs used for other neuropathic pains. The drug therapy of trigeminal postherpetic neuralgia is similar to that of other neuropathic trigeminal pain conditions.

Keywords

trigeminal neuralgia; neuropathic trigeminal pain; treatment

Cite and Share

C. Peter N. Watson. Management Issues of Neuropathic Trigeminal Pain from a Medical Perspective. Journal of Oral & Facial Pain and Headache. 2004. 18(4);366-373.

References

1. Bergouignan M. Cures hereuses de névralgies faciales essentielles par le diphenylhydantoin de soude. Rev Laryngol Otol Rhinol 1942;63:34–42.

2. Trousseau A. De la névralgie épileptiforme. Arch Gen Med 1853;1:33–44.

3. Blom S. Trigeminal neuralgia: Its treatment with a new anticonvulsant drug (G-32883). Lancet 1962;1:839–840.

4. Blom S. Tic douloureux treated with new anticonvulsant; Experience with G 32883. Arch Neurol 1963;9:285–290.

5. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217–227.

6. Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83:389–400.

7. Collins SL, Moore RA, McQuay HJ, Wiffen P. Anti-depressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 2000;20:449–458.

8. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial. Neurology 2003;60: 1284–1289.

9. Rice AS, Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001;94: 215–224.

10. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274–1283.

11. Watson CPN, Babul N. Oxycodone relieves neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:1837–1841.

12. Watson CPN, Moulin D, Watt-Watson JH, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71–78.

13. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes. A randomized, double-blind, placebo-controlled study. Pain 2003;106:151–158.

14. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: A systematic review. BMJ 1995;311:1047–1052.

15. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29:265–267.

16. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia: Use of side effects. Arch Neurol 1968;19: 129–136.

17. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial. Pain 1997;73:223–230.

18. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: Double-blind study and long-term follow-up. Ann Neurol 1984;15:240–244.

19. Kiluk KI, Knighton RS, Newman JD. The treatment of trigeminal neuralgia and other facial pain with carba-mazepine. Mich Med 1968;67:1066–1069.

20. Nicol CF. A four year double-blind study of Tegretol in facial pain. Headache 1969;9:54–57.

21. Rockliff AW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15:129–136.

22. Vilming ST, Lyberg T, Lataste X. Tizanidine in the man-agement of trigeminal neuralgia. Cephalalgia 1986;6: 181–182.

23. Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987;28:45–50.

24. Lechin F, van der Dijs B, Lechin ME, et al. Pimozide ther-apy for trigeminal neuralgia. Arch Neurol 1989;46; 960–963.

25. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clinical Journal of Pain 2002;18:22–27.

26. Fromm GH, Terrence CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987;37:1725–1728.

27. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline in chronic facial pain. Pain 1987;31:199–209.

28. Watson CPN, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671–673.

29. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427–1432.

30. Kishore-Kumar R, Max MB, Schafer SC. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305–312.

31. Watson CPN, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossover trial. Pain 1992; 48:29–36.

32. Watson CPN, Vernich L, Chipman M, Reed K. Nortripty-line versus amitriptyline in postherpetic neuralgia: A ran-domized trial. Neurology 1998;51:1166–1171.

33. Watson CPN, Evans RJ, Watt VR, Birkett N. Postherpetic neuralgia: 208 cases. Pain 1988;35:289–297.

34. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998; 280:1837–1842.

35. Watson CPN. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994;9:425–433.

36. Rowbotham MD, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: Double-blind controlled study of a new treatment method for postherpetic neuralgia. Pain 1996;65:39–44.

37. Watson CPN, Watt VR, Chipman M, Birkett N, Evans J. The prognosis with postherpetic neuralgia. Pain 1991; 46:195–199.

38. Bennett GJ. Neuropathic pain in the orofacial region: Clinical and research challenges. J Orofac Pain 2004;18: 281–286.

39. Truelove E. Management issues of neuropathic trigeminal pain from a dental perspective. J Orofac Pain 2004;18: 374–380.

Abstracted / indexed in

Science Citation Index (SCI)

Science Citation Index Expanded (SCIE)

BIOSIS Previews

Scopus

Cumulative Index to Nursing and Allied Health Literature (CINAHL)

Submission Turnaround Time

Conferences

Top